Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Sparano, JA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 58 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Sparano, JA
      Clinical aspects and management of AIDS-related lymphoma

      EUROPEAN JOURNAL OF CANCER
    2. Sparano, JA; Malik, U; Rajdev, L; Sarta, C; Hopkins, U; Wolff, AC
      Phase I trial of pegylated liposomal doxorubicin and docetaxel in advancedbreast cancer

      JOURNAL OF CLINICAL ONCOLOGY
    3. Sparano, JA; Winer, EP
      Liposomal anthracyclines for breast cancer

      SEMINARS IN ONCOLOGY
    4. Sparano, JA
      Cardiac toxicity of trastuzumab (Herceptin): Implications for the design of adjuvant trials

      SEMINARS IN ONCOLOGY
    5. Ambinder, RF; Sparano, JA
      Primary central nervous system lymphoma

      HIV & HTLV-I ASSOCIATED MALIGNANCIES
    6. Sparano, JA; Kalkut, G
      Special considerations regarding antiretroviral therapy and infection prophylaxis in the HIV-infected individual with cancer

      HIV & HTLV-I ASSOCIATED MALIGNANCIES
    7. Zafonte, BT; Hulit, J; Amanatullah, DF; Albanese, C; Wang, CG; Rosen, E; Reutens, A; Sparano, JA; Lisanti, MP; Pestell, RG
      Cell-cycle dysregulation in breast cancer: Breast cancer therapies targeting the cell cycle

      FRONTIERS IN BIOSCIENCE
    8. Sparano, JA; Rajdev, L
      Taxane-based therapy for breast cancer: Combination or sequential therapy?

      CANCER INVESTIGATION
    9. Sparano, JA; O'Neill, A; Schaefer, PL; Falkson, CI; Wood, WC
      Phase II trial of doxorubicin and docetaxel plus granulocyte colony-stimulating factor in metastatic breast cancer: Eastern Cooperative Oncology Group Study E1196

      JOURNAL OF CLINICAL ONCOLOGY
    10. Sparano, JA; Wolff, AC; Brown, D
      Troponins for predicting cardiotoxicity from cancer therapy

      LANCET
    11. Sparano, JA; Anand, K; Desai, J; Mitnick, RJ; Kalkut, GE; Hanau, LH
      Effect of highly active antiretroviral therapy on the incidence of HIV-associated malignancies at an urban medical center

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY
    12. Sparano, JA; Speyer, J; Gradishar, WJ; Liebes, L; Sridhara, R; Mendoza, S; Fry, D; Egorin, MJ
      Phase I trial of escalating doses of paclitaxel plus doxorubicin and dexrazoxane in patients with advanced breast cancer

      JOURNAL OF CLINICAL ONCOLOGY
    13. Sparano, JA; Hu, P; Rao, RM; Falkson, CI; Wolff, AC; Wood, WC
      Phase II trial of doxorubicin and paclitaxel plus granulocyte colony-stimulating factor in metastatic breast cancer: An eastern cooperative oncology group study

      JOURNAL OF CLINICAL ONCOLOGY
    14. Racevskis, J; Dill, A; Sparano, JA; Ruan, HD
      Molecular cloning of LMO4, a new human LIM domain gene

      BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION
    15. Sparano, JA
      Doxorubicin/taxane combinations: Cardiac toxicity and pharmacokinetics

      SEMINARS IN ONCOLOGY
    16. Desai, J; Mitnick, RJ; Henry, DH; Llena, J; Sparano, JA
      Patterns of central nervous system recurrence in patients with systemic human immunodeficiency virus-associated non-Hodgkin lymphoma

      CANCER
    17. Alpaugh, RK; von Mehren, M; Palazzo, I; Atkins, MB; Sparano, JA; Schuchter, L; Weiner, LM; Dutcher, JP
      Phase IB trial for malignant melanoma using R24 monoclonal antibody, interleukin-2/alpha-interferon

      MEDICAL ONCOLOGY
    18. Sparano, JA; Wiernik, PH; Hu, XP; Sarta, C; Henry, DH; Ratech, H
      Saquinavir enhances the mucosal toxicity of infusional cyclophosphamide, doxorubicin, and etoposide in patients with HIV-associated non-Hodgkin's lymphoma

      MEDICAL ONCOLOGY
    19. SPARANO JA
      USE OF DEXRAZOXANE AND OTHER STRATEGIES TO PREVENT CARDIOMYOPATHY ASSOCIATED WITH DOXORUBICIN-TAXANE COMBINATIONS

      Seminars in oncology
    20. Sparano, JA
      Compilation of phase I and II trial data of docetaxel and doxorubicin in the treatment of advanced breast cancer and other malignancies

      SEMINARS IN ONCOLOGY
    21. ISKAROS BF; HU XP; SPARANO JA; FINEBERG SA
      TENASCIN PATTERN OF EXPRESSION AND ESTABLISHED PROGNOSTIC FACTORS IN INVASIVE BREAST-CARCINOMA

      Journal of surgical oncology
    22. SPARANO JA; HU XP; WIERNIK PH; SARTA C; REDDY D; HANAU L
      OPPORTUNISTIC INFECTION AND IMMUNOLOGICAL FUNCTION IN PATIENTS WITH AIDS-ASSOCIATED LYMPHOMA TREATED WITH CHEMOTHERAPY

      Journal of acquired immune deficiency syndromes and human retrovirology
    23. SPARANO JA; WIERNIK PH; HU XP; SARTA C; DOMENECH G; CIOCZEK H; RACEVSKIS J
      INFUSIONAL CYCLOPHOSPHAMIDE, DOXORUBICIN, AND ETOPOSIDE (CDE) FOR HIV-ASSOCIATED NON-HODGKINS-LYMPHOMA (NHL) - LONG-TERM FOLLOW-UP AND ANALYSIS OF PROGNOSTIC FACTORS

      Journal of acquired immune deficiency syndromes and human retrovirology
    24. KABAT GC; CHANG CJ; SPARANO JA; SEPKOVIC DW; HU XP; KHALIL A; ROSENBLATT R; BRADLOW HL
      URINARY ESTROGEN METABOLITES AND BREAST-CANCER - A CASE-CONTROL STUDY

      Cancer epidemiology, biomarkers & prevention
    25. SPARANO JA; NEUBERG D; GLICK JH; ROBERT NJ; GOLDSTEIN LJ; SLEDGE GW; WOOD W
      PHASE-II TRIAL OF BIWEEKLY PACLITAXEL AND CISPLATIN IN ADVANCED BREAST-CARCINOMA - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY

      Journal of clinical oncology
    26. KABAT GC; CHANG CJ; SPARANO JA; SEPKOVIC DV; HU XP; KHALIL A; ROSENBLATT R; BRADLOW HL
      URINARY ESTROGEN METABOLITES AND BREAST-CANCER - A CASE-CONTROL STUDY

      American journal of epidemiology
    27. SPARANO JA; HU XP; WIERNIK PH; SARTA C; REDDY DM; HANAU L; HENRY DH
      OPPORTUNISTIC INFECTION AND IMMUNOLOGICAL FUNCTION IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS - ASSOCIATED NON-HODGKINS-LYMPHOMA TREATEDWITH CHEMOTHERAPY

      Journal of the National Cancer Institute
    28. SPARANO JA; ROBERT N; SILVERMAN P; LAZARUS H; MALIK U; VENKATRAJ U; SARTA C
      PHASE-I TRIAL OF HIGH-DOSE MITOXANTRONE PLUS CYCLOPHOSPHAMIDE AND FILGRASTIM IN PATIENTS WITH ADVANCED BREAST-CARCINOMA

      Journal of clinical oncology
    29. SPARANO JA; WIERNIK PH; HU XP; SARTA C; SCHWARTZ EL; SOEIRO R; HENRY DH; MASON B; RATECH H; DUTCHER JP
      PILOT TRIAL OF INFUSIONAL CYCLOPHOSPHAMIDE, DOXORUBICIN, AND ETOPOSIDE PLUS DIDANOSINE AND FILGRASTIM IN PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED NON-HODGKINS-LYMPHOMA

      Journal of clinical oncology
    30. SPARANO JA; LIPSITZ S; WADLER S; HANSEN R; BUSHUNOW PW; KIRKWOOD J; FLYNN PJ; DUTCHER JP; BENSON AB
      PHASE-II TRIAL OF PROLONGED CONTINUOUS-INFUSION OF 5-FLUOROURACIL ANDINTERFERON-ALPHA IN PATIENTS WITH ADVANCED PANCREATIC-CANCER - EASTERN-COOPERATIVE-ONCOLOGY-GROUP PROTOCOL-3292

      American journal of clinical oncology
    31. ROSENBLATT R; FINEBERG SA; SPARANO JA; KALEYA RN
      STEREOTAXIC CORE NEEDLE-BIOPSY OF MULTIPLE SITES IN THE BREAST - EFFICACY AND EFFECT ON PATIENT-CARE

      Radiology
    32. ISKAROS B; HU X; SPARANO JA; FINEBERG S
      APOPTOSIS IN INVASIVE BREAST-CARCINOMA - CORRELATION WITH GRADE, HORMONE RECEPTORS, AND SURVIVAL

      Laboratory investigation
    33. SENO R; SPARANO JA; FINEBERG S
      DOES NEOADJUVANT CHEMOTHERAPY (NAC) ALTER BIOLOGICAL MARKERS IN LOCALLY ADVANCED BREAST-CANCER (LABC)

      Laboratory investigation
    34. SENO R; SPARANO JA; FINEBERG S
      GROSS AND HISTOLOGIC FEATURES OF LOCALLY ADVANCED BREAST-CANCER (LABC) AFTER NEOADJUVANT CHEMOTHERAPY (NAC)

      Laboratory investigation
    35. LEVY RJ; SPARANO JA; KHAN G
      RHABDOMYOLYSIS - AN UNUSUAL COMPLICATION OF CYTOTOXIC CHEMOTHERAPY

      Medical oncology
    36. KHALIL A; CIOBANU N; SPARANO JA; GUCALP R; DUTCHER JP; WIERNIK PH
      PILOT-STUDY OF HIGH-DOSE MITOXANTRONE AND BUSULFAN PLUS AUTOLOGOUS BONE TRANSPLANTATION IN PATIENTS WITH ADVANCED MALIGNANCIES

      Bone marrow transplantation
    37. COBLEIGH MA; BERRIS RF; BUSH T; DAVIDSON NE; ROBERT NJ; SPARANO JA; TORMEY DC; WOOD WC
      ESTROGEN REPLACEMENT THERAPY IN BREAST-CANCER SURVIVORS - REPLY

      JAMA, the journal of the American Medical Association
    38. COBLEIGH MA; BERRIS RF; BUSH T; DAVIDSON NE; ROBERT NJ; SPARANO JA; TORMEY DC; WOOD WC
      ESTROGEN REPLACEMENT THERAPY IN BREAST-CANCER SURVIVORS - A TIME FOR CHANGE (VOL 272, PG 540, 1994)

      JAMA, the journal of the American Medical Association
    39. SLEDGE GW; ROBERT N; SPARANO JA; COGLEIGH M; GOLDSTEIN LJ; NEUBERG D; ROWINSKY E; BAUGHMAN C; MCCASKILLSTEVENS W
      EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDIES OF PACLITAXEL AND DOXORUBICIN IN ADVANCED BREAST-CANCER

      Seminars in oncology
    40. ROSENBLATT R; FEINBERG SA; SPARANO JA; KALEYA RN
      STEREOTAXIC BREAST CORE-NEEDLE BIOPSY OF MULTIPLE SITES - EFFICACY AND IMPACT ON MANAGEMENT

      Radiology
    41. SPARANO JA; WIERNIK PH; HU X; DUTCHER JP; SARTA C; HENRY D; MASON B
      DIDANOSINE (DDI) AMELIORATES NEUTROPENIA AND THROMBOCYTOPENIA IN PATIENTS WITH HIV-ASSOCIATED NON-HODGKINS-LYMPHOMA (NHL) TREATED WITH INFUSIONAL CYCLOPHOSPHAMIDE (C), DOXORUBICIN (D), AND ETOPOSIDE (E) PLUS GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF)

      Blood
    42. WIERNIK PH; SKLARIN NT; DUTCHER JP; SPARANO JA; GREENWALD ES
      ADJUVANT RADIOTHERAPY FOR BREAST-CANCER AS A RISK FACTOR FOR THE DEVELOPMENT OF LUNG-CANCER

      Medical oncology
    43. SPARANO JA; OBOYLE K
      IMMUNOLOGICAL THERAPY OF BREAST-CANCER - CURRENT STATUS AND FUTURE POTENTIAL

      CLINICAL IMMUNOTHERAPEUTICS
    44. SPARANO JA; FISHER RI; WEISS GR; MARGOLIN K; ARONSON FR; HAWKINS MJ; ATKINS MB; DUTCHER JP; GAYNOR ER; BOLDT DH; DOROSHOW JH; ERNEST ML; SZNOL M; MIER JW
      PHASE-II TRIALS OF HIGH-DOSE INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELLS IN ADVANCED BREAST-CARCINOMA AND CARCINOMA OF THE LUNG, OVARY, AND PANCREAS AND OTHER TUMORS

      Journal of immunotherapy with emphasis on tumor immunology
    45. SPARANO JA; WIERNIK PH; STRACK M; LEAF A; BECKER NH; SARTA C; CARNEY D; ELKIND R; SHAH M; VALENTINE ES; DUTCHER JP
      INFUSIONAL CYCLOPHOSPHAMIDE, DOXORUBICIN AND ETOPOSIDE IN HIV-RELATEDNON-HODGKINS-LYMPHOMA - A FOLLOW-UP REPORT OF A HIGHLY-ACTIVE REGIMEN

      Leukemia & lymphoma
    46. ATKINS MB; OBOYLE KR; SOSMAN JA; WEISS GR; MARGOLIN KA; ERNEST ML; KAPPLER K; MIER JW; SPARANO JA; FISHER RI; ECKARDT JR; PEREIRA C; ARONSON FR
      MULTIINSTITUTIONAL PHASE-II TRIAL OF INTENSIVE COMBINATION CHEMOIMMUNOTHERAPY FOR METASTATIC MELANOMA

      Journal of clinical oncology
    47. WADLER S; TENTEROMANO L; CAZENAVE L; SPARANO JA; GREENWALD ES; ROZENBLIT A; KALEYA R; WIERNIK PH
      PHASE-II TRIAL OF ECHINOMYCIN IN PATIENTS WITH ADVANCED OR RECURRENT COLORECTAL-CANCER

      Cancer chemotherapy and pharmacology
    48. COBLEIGH MA; BERRIS RF; BUSH T; DAVIDSON NE; ROBERT NJ; SPARANO JA; TORMEY DC; WOOD WC
      ESTROGEN REPLACEMENT THERAPY IN BREAST-CANCER SURVIVORS - A TIME FOR CHANGE

      JAMA, the journal of the American Medical Association
    49. SLEDGE GW; ROBERT N; SPARANO JA; COBELIGH M; GOLDSTEIN LJ; NEUBERG D; ROWINSKY E; BAUGHMAN C; MCCASKILLSTEVENS W
      PACLITAXEL (TAXOL) DOXORUBICIN COMBINATIONS IN ADVANCED BREAST-CANCER- THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP EXPERIENCE

      Seminars in oncology
    50. SPARANO JA; WADLER S; DIASIO RB; ZHANG RW; LU ZH; SCHWARTZ EL; EINZIG A; WIERNIK PH
      PHASE-I TRIAL OF LOW-DOSE, PROLONGED CONTINUOUS-INFUSION FLUOROURACILPLUS INTERFERON-ALFA - EVIDENCE FOR ENHANCED FLUOROURACIL TOXICITY WITHOUT PHARMACOKINETIC PERTURBATION

      Journal of clinical oncology
    51. SPARANO JA; WIERNIK PH; LEAF A; DUTCHER JP
      INFUSIONAL CYCLOPHOSPHAMIDE, DOXORUBICIN, AND ETOPOSIDE IN RELAPSED AND RESISTANT NON-HODGKINS-LYMPHOMA - EVIDENCE FOR A SCHEDULE-DEPENDENTEFFECT FAVORING INFUSIONAL ADMINISTRATION OF CHEMOTHERAPY

      Journal of clinical oncology
    52. SPARANO JA; FISHER RI; SUNDERLAND M; MARGOLIN K; ERNEST ML; SZNOL M; ATKINS MB; DUTCHER JP; MICETICH KC; WEISS GR; DOROSHOW JH; ARONSON FR; RUBINSTEIN LV; MIER JW
      RANDOMIZED PHASE-III TRIAL OF TREATMENT WITH HIGH-DOSE INTERLEUKIN-2 EITHER ALONE OR IN COMBINATION WITH INTERFERON ALFA-2A IN PATIENTS WITH ADVANCED MELANOMA

      Journal of clinical oncology
    53. SPARANO JA; WADLER S; SCHWARTZ EL; DIASIO R
      CLINICAL AND PHARMACOLOGICAL STUDIES OF INTERFERON AND CHEMOTHERAPY IN GASTROINTESTINAL AND BREAST-CANCER

      International journal of clinical pharmacology research
    54. SPARANO JA; WADLER S; LIEBES L; ROBERT NJ; SCHWARTZ EL; DUTCHER JP
      PHASE-I TRIAL OF CYCLOPHOSPHAMIDE, DOXORUBICIN, AND 5-FLUOROURACIL PLUS INTERFERON-ALPHA-2B IN PATIENTS WITH ADVANCED BREAST-CANCER

      Cancer research
    55. SPARANO JA; WIERNIK PH; DUTCHER JP; LEAF A; KHALIL A
      INFUSIONAL CYCLOPHOSPHAMIDE (C), DOXORUBICIN (D), AND ETOPOSIDE (E) IN RELAPSED, RESISTANT, AND POOR-PROGNOSIS NON-HODGKINS-LYMPHOMA (NHL) - A FOLLOW-UP REPORT

      Blood
    56. SPARANO JA; WIERNIK PH; DUTCHER JP; SARTA C; STRACK M; LEAF A
      INFUSIONAL CYCLOPHOSPHAMIDE-(C), DOXORUBICIN-(D), AND ETOPOSIDE-(E) IN HIV-RELATED NON-HODGKINS-LYMPHOMA (NHL) - A FOLLOW-UP REPORT OF A HIGHLY-ACTIVE REGIMEN

      Blood
    57. CIOBANU N; LAZARUS HM; DEBELLIS R; ASCENSAO J; SPARANO JA; GUCALP R; DUTCHER J; FOX RM; CREGER RJ; COOPER BW; GERSON SL; NESE M; BELLO L; WIEMIK PH
      AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) USING EX-VIVO ETOPOSIDE(VP-16) PURGED MARROW IN PATIENTS (PTS) WITH POOR-RISK LYMPHOMAS (LY)AND ACUTE LEUKEMIAS (LEUK)

      Blood
    58. SPARANO JA; WIERNIK PH; STRACK M; LEAF A; BECKER N; VALENTINE ES
      INFUSIONAL CYCLOPHOSPHAMIDE, DOXORUBICIN, AND ETOPOSIDE IN HUMAN-IMMUNODEFICIENCY-VIRUS CELL AND HUMAN T-CELL LEUKEMIA-VIRUS TYPE-I RELATEDNON-HODGKINS-LYMPHOMA - A HIGHLY-ACTIVE REGIMEN

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 19/01/21 alle ore 23:23:10